BioAtla

-$0.08 (-3.35%) As of 1:53 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.

About BCAB

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.

CEO
Jay M. Short
Employees
56
Headquarters
San Diego, California
Founded
2007

BCAB Key Statistics

Market cap
86.43M
Price-Earnings ratio
—
Dividend yield
—
Average volume
996.01K
High today
$2.31
Low today
$2.28
Open price
$2.30
Volume
30.32K
52 Week high
$51.83
52 Week low
$2.01

BCAB Earnings

-$1.50
-$0.79
-$0.07
$0.64
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.67 per share
Actual
Available May 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure